Human IGFBP7 ELISA Kit (A105223)

Human IGFBP7 ELISA Kit

Sandwich (quantitative)

This IGFBP7 enzyme linked immunosorbent assay (ELISA) applies a technique called a quantitative sandwich immunoassay. The microtiter plate has been pre-coated with an Anti-IGFBP7 Antibody. Standards or samples are then added to the microtire plate wells and IGFBP7, if present, will bind to the antibody pre-coated on the wells. In order to quantify the amount of IGFBP7 present in the sample, Anti-IGFBP7 Antibody (Biotin) is added to each well to "sandwich" the IGFBP7 immobilised on the plate. The microtiter plate then undergoes incubation, followed by thorough washing of the wells to remove all unbound components. Next, Avidin-Biotin-Peroxidase Complex is added to each well for a short incubation period, followed by thorough washing of the wells to remove all unbound conjugates. Next, a TMB (3,3',5,5' tetramethyl-benzidine) substrate solution is added to each well. The enzyme (HRP) and substrate are allowed to react over a short incubation period. Only those wells that contain IGFBP7 will exhibit a change in colour. The enzyme-substrate reaction is terminated by the addition of a stop solution and the colour change is measured spectrophotometrically at a wavelength of 450nm ± 2nm.

Microplate

Serum, body fluids, tissue homogenate, and cell culture supernatants.

< 5 pg/ml

625-40,000 pg/ml

Human

Store at 2-8°C for 6 months or at -20°C for 12 months.

AGM, Angiomodulin, FSTL2, IBP-7, IBP7, IBP7_HUMAN, IGF binding protein 7, IGF-binding protein 7, IGFBP rP1, IGFBP-7, IGFBP-rP1, IGFBPRP1, Insulin like growth factor binding protein 7, Insulin-like growth factor-binding protein 7, MAC25, MAC25 protein, PGI2 stimulating factor, PGI2-stimulating factor, Prostacyclin stimulating factor, Prostacyclin-stimulating factor, PSF, RAMSVPS, TAF, Tumor-derived adhesion factor